Oncology Devices Market Size, Share, Trends, Growth Outlook

Oncology Devices Market is estimated to increase at a growth rate of 16.8% CAGR over the forecast period from 2024 to 2030.

The global Oncology Devices Marketstudy analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Device (Brachytherapy Devices, Endoscopic Devices), By Therapy (Chemotherapy, Hormone Therapy, Biotherapy/Immunotherapy, Radiation Therapy), By End-user (Hospitals, Cancer Research Institutes, Others).

An introduction to Oncology Devices Market in 2024

Supporting cancer diagnosis, treatment, and supportive care, the Oncology Devices market offers a diverse array of medical devices and equipment for oncology clinics, hospitals, and research laboratories. Oncology devices include diagnostic imaging systems (e.g., PET-CT, MRI), radiation therapy equipment (e.g., linear accelerators, brachytherapy systems), surgical instruments (e.g., biopsy needles, electrosurgical devices), and supportive care devices (e.g., infusion pumps, central venous catheters) designed to improve patient outcomes and quality of life across the cancer care continuum. The market's growth is driven by technological advancements in oncology devices, increasing incidence of cancer, and investments in cancer care infrastructure and supportive technologies worldwide.

Oncology Devices market Trend: Advancements in Minimally Invasive Surgical Techniques

A significant trend in the Oncology Devices market is the continual advancements in minimally invasive surgical techniques. As surgical oncology evolves, there is a notable shift towards minimally invasive procedures, such as laparoscopic surgery, robotic-assisted surgery, and image-guided interventions. These advanced surgical techniques offer benefits such as reduced postoperative pain, shorter hospital stays, faster recovery times, and improved cosmetic outcomes for cancer patients. This trend reflects a broader emphasis on enhancing patient outcomes, reducing healthcare costs, and improving quality of life through less invasive approaches to cancer treatment. As a result, there is increasing demand for oncology devices designed specifically for minimally invasive procedures, driving innovation in surgical instrumentation, imaging technologies, and surgical navigation systems tailored for oncological applications.

Oncology Devices market Driver: Growing Incidence of Cancer and Rising Demand for Oncological Procedures

The primary driver propelling the Oncology Devices market is the growing incidence of cancer and the rising demand for oncological procedures. With cancer continuing to be a leading cause of morbidity and mortality worldwide, there is significant demand for oncology devices used in the diagnosis, treatment, and management of various malignancies. From diagnostic imaging equipment and radiation therapy systems to surgical instruments and implantable devices, oncology devices play a critical role in the multidisciplinary approach to cancer care. The increasing prevalence of cancer, coupled with advancements in early detection, screening programs, and treatment modalities, is driving the adoption of oncology devices across healthcare settings, including hospitals, ambulatory surgery centers, and specialty clinics. The growing demand for oncological procedures and interventions is fueling market growth for a wide range of oncology devices, creating opportunities for device manufacturers, healthcare providers, and medical technology companies to innovate and expand their product portfolios to meet the evolving needs of cancer patients and healthcare professionals.

Oncology Devices market Opportunity: Development of Personalized Oncology Devices and Patient-Specific Implants

An exciting opportunity in the Oncology Devices market lies in the development of personalized oncology devices and patient-specific implants. With the advent of precision medicine and personalized oncology approaches, there is increasing recognition of the importance of tailoring cancer treatments to individual patient characteristics, tumor biology, and genetic profiles. Contract medical device manufacturers and technology companies can capitalize on this opportunity by leveraging advanced manufacturing techniques, such as 3D printing and additive manufacturing, to create customized oncology devices, surgical instruments, and patient-specific implants optimized for individual patient anatomy and treatment requirements. By offering personalized oncology devices, such as customized surgical guides, implantable prostheses, and brachytherapy applicators, manufacturers can enhance treatment precision, improve therapeutic outcomes, and minimize complications for cancer patients undergoing surgical interventions or radiation therapy. Moreover, personalized oncology devices have the potential to streamline surgical workflows, reduce intraoperative variability, and optimize resource utilization in oncological procedures, contributing to the advancement of personalized cancer care and the overall improvement of patient outcomes in oncology practice.

Oncology Devices Market Market Segmentation

By Device
Brachytherapy Devices
Endoscopic Devices
By Therapy
Chemotherapy
Hormone Therapy
Biotherapy/Immunotherapy
Radiation Therapy
By End-User
Hospitals
Cancer Research Institutes
Others

Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Oncology Devices Market Companies

Accuray Inc
Alpha Tau Medical
Becton Dickinson and Company
Biogenex Laboratories
Brainlab
Canon Medical Systems Corp
Eckert & Ziegler BEBIG GmbH
Elekta AB
GE Healthcare
Hologic Inc
IBA AG
IBA Group
IsoRay
Medtronic PLC
Mevion Medical Systems
Mirada Medical Ltd
Nanobiotix
Navidea Biopharmaceuticals Inc
Oncura Inc
PerkinElmer
Philips Healthcare
RaySearch Laboratories
RefleXion Medical
Roche Diagnostics
Siemens Healthineers
Theragenics Corp
Varian Medical Systems Inc
ViewRay Inc
Vision RT

Reasons to Buy the Oncology Devices Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Oncology Devices Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Oncology Devices Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Oncology Devices Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Oncology Devices Market Size Outlook, $ Million, 2021 to 2030
3.2 Oncology Devices Market Outlook by Type, $ Million, 2021 to 2030
3.3 Oncology Devices Market Outlook by Product, $ Million, 2021 to 2030
3.4 Oncology Devices Market Outlook by Application, $ Million, 2021 to 2030
3.5 Oncology Devices Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Oncology Devices Industry
4.2 Key Market Trends in Oncology Devices Industry
4.3 Potential Opportunities in Oncology Devices Industry
4.4 Key Challenges in Oncology Devices Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Oncology Devices Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Oncology Devices Market Outlook by Segments
7.1 Oncology Devices Market Outlook by Segments, $ Million, 2021- 2030
By Device
Brachytherapy Devices
Endoscopic Devices
By Therapy
Chemotherapy
Hormone Therapy
Biotherapy/Immunotherapy
Radiation Therapy
By End-User
Hospitals
Cancer Research Institutes
Others

8 North America Oncology Devices Market Analysis and Outlook To 2030
8.1 Introduction to North America Oncology Devices Markets in 2024
8.2 North America Oncology Devices Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Oncology Devices Market size Outlook by Segments, 2021-2030
By Device
Brachytherapy Devices
Endoscopic Devices
By Therapy
Chemotherapy
Hormone Therapy
Biotherapy/Immunotherapy
Radiation Therapy
By End-User
Hospitals
Cancer Research Institutes
Others

9 Europe Oncology Devices Market Analysis and Outlook To 2030
9.1 Introduction to Europe Oncology Devices Markets in 2024
9.2 Europe Oncology Devices Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Oncology Devices Market Size Outlook by Segments, 2021-2030
By Device
Brachytherapy Devices
Endoscopic Devices
By Therapy
Chemotherapy
Hormone Therapy
Biotherapy/Immunotherapy
Radiation Therapy
By End-User
Hospitals
Cancer Research Institutes
Others

10 Asia Pacific Oncology Devices Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Oncology Devices Markets in 2024
10.2 Asia Pacific Oncology Devices Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Oncology Devices Market size Outlook by Segments, 2021-2030
By Device
Brachytherapy Devices
Endoscopic Devices
By Therapy
Chemotherapy
Hormone Therapy
Biotherapy/Immunotherapy
Radiation Therapy
By End-User
Hospitals
Cancer Research Institutes
Others

11 South America Oncology Devices Market Analysis and Outlook To 2030
11.1 Introduction to South America Oncology Devices Markets in 2024
11.2 South America Oncology Devices Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Oncology Devices Market size Outlook by Segments, 2021-2030
By Device
Brachytherapy Devices
Endoscopic Devices
By Therapy
Chemotherapy
Hormone Therapy
Biotherapy/Immunotherapy
Radiation Therapy
By End-User
Hospitals
Cancer Research Institutes
Others

12 Middle East and Africa Oncology Devices Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Oncology Devices Markets in 2024
12.2 Middle East and Africa Oncology Devices Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Oncology Devices Market size Outlook by Segments, 2021-2030
By Device
Brachytherapy Devices
Endoscopic Devices
By Therapy
Chemotherapy
Hormone Therapy
Biotherapy/Immunotherapy
Radiation Therapy
By End-User
Hospitals
Cancer Research Institutes
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Accuray Inc
Alpha Tau Medical
Becton Dickinson and Company
Biogenex Laboratories
Brainlab
Canon Medical Systems Corp
Eckert & Ziegler BEBIG GmbH
Elekta AB
GE Healthcare
Hologic Inc
IBA AG
IBA Group
IsoRay
Medtronic PLC
Mevion Medical Systems
Mirada Medical Ltd
Nanobiotix
Navidea Biopharmaceuticals Inc
Oncura Inc
PerkinElmer
Philips Healthcare
RaySearch Laboratories
RefleXion Medical
Roche Diagnostics
Siemens Healthineers
Theragenics Corp
Varian Medical Systems Inc
ViewRay Inc
Vision RT
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Device
Brachytherapy Devices
Endoscopic Devices
By Therapy
Chemotherapy
Hormone Therapy
Biotherapy/Immunotherapy
Radiation Therapy
By End-User
Hospitals
Cancer Research Institutes
Others